To confirm the diagnosis of LS, testing for the somatic BRAF V600E mutation is useful, as it is found in 69–78% of CRC patients with MLH1 promoter methylation [58] and not present in the vast majority of LS cases [59]. This evidence concerns the gene BRAF and colorectal carcinoma.